liposomal glutathione and parkinson's disease Targeting the Cysteine Redox Proteome in Disease: The Role of Precursors Beyond Nanotechnology-based advancements in Parkinson's therapy:
Description
doi: 10.1042/bj1550697
(1988) in Zuckerman, A
[DOI] [PubMed] [Google Scholar] 113.Aqai P., Peters J., Gerssen A., Haasnoot W., Nielen M
The drug reduces glomerular filtration, the process by which the kidneys filter excess fluid and waste products into the urine, thereby straining the kidneys
EGCG has potential for treating age-related cognitive decline and mild cognitive impairment by enhancing synaptic plasticity, promoting adult neurogenesis, improving cerebral blood flow and glucose metabolism, reducing oxidative stress and inflammation, and promoting cellular repair mechanisms
